Intuitive Surgical protected hospitals in 2020 and da Vinci demand snapped back

COVID hit Intuitive Surgical at the weak point of its da Vinci model: hospitals deferred procedures and capital purchases. In early 2020, China procedures fell about 90% from early January weekly rates, and Western Europe and the U.S. saw sharp declines in March.

Intuitive chose to keep the platform warm. It gave customers service-fee credits, extended payment terms, deferred lease payments, and launched extended-use instruments in the U.S. and Europe to lower per-procedure cost. The relief program reduced 2020 service revenue by $80 million, but it kept hospital relationships intact.

When procedures recovered, demand followed. In 2021, revenue rose 31% to $5.7 billion, da Vinci procedures rose 28% to about 1.59 million, and system placements rose 44% to 1,347. The company said deferred 2020 purchases, procedure growth and upgrades to fourth-generation systems all fed the rebound.

2021 revenue rose 31% to $5.7B, da Vinci procedures rose 28%, and system placements rose 44% to 1,347.

The relief credits acknowledged that hospitals, not just Intuitive, were under financial stress.

Extended-use instruments traded some revenue per procedure for lower adoption friction.

Leasing and usage-based arrangements gave hospitals a way to add or upgrade robots without a full upfront purchase.

When customers' own economics freeze, protecting their ability to keep using the platform can matter more than preserving near-term revenue.

Intuitive exited the shock with a larger installed base and more recurring revenue. By the end of 2021, it had about 6,730 da Vinci systems installed, and recurring revenue made up 75% of total revenue.